Ensituximab (NEO-102) is a quasi-selective IgG1 monoclonal antibody against the MUC5AC variant with anti-tumour activity that inhibits colorectal and pancreatic cancer.
CAS Number:
[1092658-06-4]
Target:
NPC-1C , NEO-101 , NEO-102
* VAT and and shipping costs not included. Errors and price changes excepted